Idera Pharmaceuticals, Inc. (NASDAQ: IDRA)

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) is focused on developing drug candidates that treat infectious diseases, autoimmune diseases, cancer, and respiratory diseases, and can be used as vaccine adjuvants. The company’s pioneering DNA and RNA chemistry expertise enables them to develop drug candidates for internal development while creating opportunities for multiple collaborative alliances. For further information, visit the Company’s web site at www.iderapharma.com.